Canton Hathaway »

Coherus Biosciences shares owned by Canton Hathaway

Quarter-by-quarter ownership of Coherus Biosciences (CHRS) shares owned by Canton Hathaway from 13F filings

Historical chart of Canton Hathaway investment in Coherus Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Coherus Biosciences held by Canton Hathaway consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Coherus Biosciences by Canton Hathaway

Quarter filed Position value Share count Share price at filing
2026-06-30 $82k 58k 1.40

More positions owned by Canton Hathaway

Berkshire Hathaway Inc A Cl A (BRK.A)
Vanguard 500 ETF Etf (VOO)
Bloom Energy Corp Class A Com Cl A (BE)
Alphabet Inc Class C cs (GOOG)
Ishares Msci Eafe Etf Etf (EFA)
Spdr Gold Tr Gold Gold Shs (GLD)
Microsoft Corporation (MSFT)
Berkshire Hathaway Inc B Cl B New (BRK.B)
Technology Select Sector SPDR ETF Etf (XLK)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Industrial Select SPDR ETF Etf (XLI)
iShares Russell 2000 Etf (IWM)
Qxo Com New (QXO)
iShares Silver Trust Etf (SLV)

View all positions for Canton Hathaway

Top funds holding Coherus Biosciences

Timothy G. Youngquist 2020 Irrevocable Trust
BlackRock
Vanguard Capital Management
Geode Capital Management
Samsara BioCapital
Kohlberg Kravis Roberts & Co
State Street Corporation
Two Sigma Investments
CM Management
CAM Group Holding A/S
Alyeska Investment Group
Hudson Bay Capital Management
AQR Capital Management
Charles Schwab Investment Management
Sixth Street Partners Management Company

View all funds holding Coherus Biosciences